| Original language | English |
|---|---|
| Pages (from-to) | 1146-1155 |
| Number of pages | 10 |
| Journal | Leukemia & Lymphoma |
| Volume | 60 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 16 Apr 2019 |
Keywords
- Acute promyelocytic leukemia
- complex karyotype
- ATRA
- chemotherapy
- prognostic
- relapse
- TRANS-RETINOIC ACID
- ADDITIONAL CHROMOSOME-ABNORMALITIES
- RISK-ADAPTED TREATMENT
- ARSENIC TRIOXIDE
- ANTHRACYCLINE MONOCHEMOTHERAPY
- PROGNOSTIC-SIGNIFICANCE
- CONSOLIDATION THERAPY
- CYTOGENETIC CHANGES
- FLT3 MUTATIONS
- PETHEMA
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy. / Labrador, Jorge; Luno, Elisa; Vellenga, Edo; Brunet, Salut; Gonzalez-Campose, Jose; Chillon, Maria C.; Holowiecka, Aleksandra; Esteve, Jordi; Bergua, Juan; Gonzalez-Sanmiguel, Jose D.; Gil, Cristina; Tormo, M.; Salamero, Olga; Manso, Felix; Fernandez, Isolda; de laSerna, Javier; Moreno, Maria-Jose; Perez-Encinas, M.; Krsnik, Isabel; Ribera, Josep-Maria; Cervera, Jose; Calasanz, Maria J.; Boluda, Blanca; Sobas, Marta; Lowenberg, Bob; Sanz, Miguel A.; Montesinos, Pau; Palmer, L.; Fernandez; Ciarlo, S.; Bezares, F.; Rojas, F.; Longoni, H.; Gelemur, M.; Fazio, P.; Canepa, C.; Saba, S.; Balladares, G.; Negri, P.; Giunta, M.; Milone, J.; Prates, M.; Lafalse, D.; Sossa, C.; Jaramillo, F.; Mayer, J.; Ramos, F.; Martinez, J.; de Groot, M. R.; Schouten, H. C.; Programa Español de Tratamientos en Hematología (PETHEMA) group; Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON); Polish Adult Leukemia Group, PALG; Grupo Argentino de Tratamiento de la Leucemia Aguda, GATLA.
In: Leukemia & Lymphoma, Vol. 60, No. 5, 16.04.2019, p. 1146-1155.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy
AU - Labrador, Jorge
AU - Luno, Elisa
AU - Vellenga, Edo
AU - Brunet, Salut
AU - Gonzalez-Campose, Jose
AU - Chillon, Maria C.
AU - Holowiecka, Aleksandra
AU - Esteve, Jordi
AU - Bergua, Juan
AU - Gonzalez-Sanmiguel, Jose D.
AU - Gil, Cristina
AU - Tormo, M.
AU - Salamero, Olga
AU - Manso, Felix
AU - Fernandez, Isolda
AU - de laSerna, Javier
AU - Moreno, Maria-Jose
AU - Perez-Encinas, M.
AU - Krsnik, Isabel
AU - Ribera, Josep-Maria
AU - Cervera, Jose
AU - Calasanz, Maria J.
AU - Boluda, Blanca
AU - Sobas, Marta
AU - Lowenberg, Bob
AU - Sanz, Miguel A.
AU - Montesinos, Pau
AU - Palmer, L.
AU - Fernandez, null
AU - Ciarlo, S.
AU - Bezares, F.
AU - Rojas, F.
AU - Longoni, H.
AU - Gelemur, M.
AU - Fazio, P.
AU - Canepa, C.
AU - Saba, S.
AU - Balladares, G.
AU - Negri, P.
AU - Giunta, M.
AU - Milone, J.
AU - Prates, M.
AU - Lafalse, D.
AU - Sossa, C.
AU - Jaramillo, F.
AU - Mayer, J.
AU - Ramos, F.
AU - Martinez, J.
AU - de Groot, M. R.
AU - Schouten, H. C.
AU - Programa Español de Tratamientos en Hematología (PETHEMA) group
AU - Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)
AU - Polish Adult Leukemia Group, PALG
AU - Grupo Argentino de Tratamiento de la Leucemia Aguda, GATLA
PY - 2019/4/16
Y1 - 2019/4/16
KW - Acute promyelocytic leukemia
KW - complex karyotype
KW - ATRA
KW - chemotherapy
KW - prognostic
KW - relapse
KW - TRANS-RETINOIC ACID
KW - ADDITIONAL CHROMOSOME-ABNORMALITIES
KW - RISK-ADAPTED TREATMENT
KW - ARSENIC TRIOXIDE
KW - ANTHRACYCLINE MONOCHEMOTHERAPY
KW - PROGNOSTIC-SIGNIFICANCE
KW - CONSOLIDATION THERAPY
KW - CYTOGENETIC CHANGES
KW - FLT3 MUTATIONS
KW - PETHEMA
U2 - 10.1080/10428194.2018.1522438
DO - 10.1080/10428194.2018.1522438
M3 - Article
C2 - 30526152
VL - 60
SP - 1146
EP - 1155
JO - Leukemia & Lymphoma
JF - Leukemia & Lymphoma
SN - 1042-8194
IS - 5
ER -